NASDAQ:APTXAptinyx Stock Price, Forecast & News

Aptinyx's stock was trading at $2.43 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, APTX stock has increased by 105.3% and is now trading at $4.99. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aptinyx in the last year. There are currently 1 sell rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aptinyx.

Aptinyx is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Aptinyx.

Aptinyx Inc (NASDAQ:APTX) released its quarterly earnings data on Thursday, May, 14th. The company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by $0.01. The company had revenue of $0.82 million for the quarter, compared to analysts' expectations of $0.91 million. Aptinyx had a negative return on equity of 47.99% and a negative net margin of 1,540.42%. View Aptinyx's earnings history.

6 analysts have issued twelve-month target prices for Aptinyx's shares. Their forecasts range from $7.00 to $15.00. On average, they expect Aptinyx's share price to reach $9.67 in the next year. This suggests a possible upside of 93.7% from the stock's current price. View analysts' price targets for Aptinyx.

Media headlines about APTX stock have trended negative on Saturday, InfoTrie reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aptinyx earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the company's share price in the near future. View the latest news about Aptinyx.

Aptinyx saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 306,100 shares, an increase of 49.6% from the May 31st total of 204,600 shares. Based on an average daily volume of 268,900 shares, the short-interest ratio is currently 1.1 days. Currently, 1.4% of the shares of the company are sold short. View Aptinyx's Current Options Chain.

Some companies that are related to Aptinyx include Retrophin (RTRX), Gossamer Bio (GOSS), Passage Bio (ORIC), ImmunoGen (IMGN), Humanigen (HGEN), Omeros (OMER), Cara Therapeutics (CARA), G1 Therapeutics (GTHX), Endo International (ENDP), Dynavax Technologies (DVAX), Morphic (MORF), Aprea Therapeutics (APRE), Stoke Therapeutics (STOK), Assembly Biosciences (ASMB) and Kadmon (KDMN). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptinyx investors own include Onconova Therapeutics (ONTX), Opko Health (OPK), VBI Vaccines (VBIV), NVIDIA (NVDA), Inovio Pharmaceuticals (INO), ADMA Biologics (ADMA), Crispr Therapeutics (CRSP), Gilead Sciences (GILD), Square (SQ) and vTv Therapeutics (VTVT).

(APTX) raised $77 million in an initial public offering on Thursday, June 21st 2018. The company issued 5,300,000 shares at a price of $14.00-$15.00 per share. J.P. Morgan, Cowen, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

Aptinyx trades on the NASDAQ under the ticker symbol "APTX."

Shares of APTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of APTX stock can currently be purchased for approximately $4.99.

Aptinyx has a market capitalization of $227.84 million and generates $3.67 million in revenue each year. The company earns $-57,410,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis.

The official website for Aptinyx is www.aptinyx.com.

Aptinyx's mailing address is 909 DAVIS STREET SUITE 600, EVANSTON IL, 60201. The company can be reached via phone at 847-871-0377 or via email at [email protected]